{"organizations": [], "uuid": "db2cfd207fda623db87317e24314bfd87079bed6", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.cnbc.com", "main_image": "", "site_section": "http://www.cnbc.com/id/10000027", "section_title": "Press Releases - CNBC", "url": "http://www.cnbc.com/2018/05/07/globe-newswire-teligent-inc-to-reschedule-conference-call-for-first-quarter-2018-results.html", "country": "US", "domain_rank": 767, "title": "Teligent, Inc. to Reschedule Conference Call for First Results", "performance_score": 0, "site": "cnbc.com", "participants_count": 1, "title_full": "", "spam_score": 0.18, "site_type": "news", "published": "2018-05-08T01:50:00.000+03:00", "replies_count": 0, "uuid": "db2cfd207fda623db87317e24314bfd87079bed6"}, "author": "cnbc.com", "url": "http://www.cnbc.com/2018/05/07/globe-newswire-teligent-inc-to-reschedule-conference-call-for-first-quarter-2018-results.html", "ord_in_thread": 0, "title": "Teligent, Inc. to Reschedule Conference Call for First Results", "locations": [], "entities": {"persons": [{"name": "damian finio teligent", "sentiment": "none"}], "locations": [{"name": "n.j.", "sentiment": "none"}, {"name": "buena", "sentiment": "none"}], "organizations": [{"name": "teligent, inc.", "sentiment": "neutral"}, {"name": "teligent, inc", "sentiment": "none"}, {"name": "company", "sentiment": "none"}, {"name": "teligent", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "BUENA, N.J., May 07, 2018 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ:TLGT), a New Jersey-based specialty generic pharmaceutical company, initially announced the Company would hold a conference call at 4:30pm ET on Monday, May 7, 2018 to discuss the 1 st quarter 2018 financial results and business update. This call will be rescheduled for 8:30am ET on Tuesday, May 8, 2018.\nThe Company invites you to listen to the call by dialing (866) 393-8366. International participants should call (409) 350-3154. Participants should ask to join the Teligent, Inc. call.\nThis call is available via webcast and can be accessed in the Investor Relations Section of Teligent, Inc.'s website at www.teligent.com .\nAbout Teligent, Inc.\nTeligent is a specialty generic pharmaceutical company. Our mission is to be a leading player in the specialty generic prescription drug market. Learn more on our website www.teligent.com .\nContact :\nDamian Finio\nTeligent, Inc.\n(856) 336-9117\nwww.teligent.com\nSource:Teligent, Inc.", "external_links": ["https://www.globenewswire.com/NewsRoom/AttachmentNg/4229d659-90ce-49ce-bd4d-b283e01f00f8", "https://www.globenewswire.com/Tracker?data=eRxLVULuZA5zKrk4Zi74Zf9gUfVkrNXDSdDBHSJRxKVKmwY1EetB6gi0SqNLYWSudhUOovPACFTJpD-6RI_u-w==", "https://www.globenewswire.com/Tracker?data=eRxLVULuZA5zKrk4Zi74ZdyICKROzMB5ukG-hDb0-4ygRpI9AT2oxk_kYFRFc4AlwPBripGC7CtgaYq6c4Ch1g==", "https://www.globenewswire.com/Tracker?data=eRxLVULuZA5zKrk4Zi74Zb43DK2b6fnWGOQE8eehN__Z-XAvdwUc2-GzS7VqAB6hSlMWwT7OUIQ-gzf0bK8zWg=="], "published": "2018-05-08T01:50:00.000+03:00", "crawled": "2018-05-08T02:32:16.012+03:00", "highlightTitle": ""}